• On-Demand

Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part I: Equitable, Guideline-based Testing for Prognosis and Treatment

  • Part of the Series: Making The Right Call
  • Available: November 29, 2022 — 
  • November 28, 2023
  • Credit: 0.30hr(s)
  • Credit Types: AAPA, CME, CPE, NCPD
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: Biomarkers, NSCLC
  • Location: Internet Activity Enduring
Enroll Today

Course Description

In the past decade, advances in non-small cell lung cancer (NSCLC) have rapidly evolved with the discovery of targetable mutations and subsequent therapies. However, suboptimal biomarker testing practices and varying adherence to testing guidelines presents a challenge to implementing targeted treatment. Are you ready to test your skills against those of your colleagues? Join us for Part 1 of this question and answer based educational activity Equitable, Guideline-based Testing for Prognosis and Treatment where our oncology experts will:
  • Review guideline recommendations for biomarker testing and treatment selection
  • Present clinical evidence for the use of current and emerging targeted therapies
  • Discuss health disparities in biomarker testing

Other Courses in this Series

Other Courses That May be of Interest

View All Events
Facebook Twitter Linkedin Instagram
Subscribe to Mailing List
Scroll to Top